A protocol for rapid detection of the 2019 novel coronavirus SARS-CoV-2 using CRISPR diagnostics: SARS-CoV-2 DETECTR v1
Mammoth Biosciences(University of California, San Francisco), Janice S. Chen(Mammoth Biosciences (United States)), Charles Y. Chiu(University of California, San Francisco), Jasmeet Singh(Mammoth Biosciences (United States)), Clare L. Fasching(Mammoth Biosciences (United States)), Wayne Deng(University of California, San Francisco), James P. Broughton(Mammoth Biosciences (United States))
Cited by 11
Related Papers
CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity
|Science|2018|4.4k
CRISPR–Cas12-based detection of SARS-CoV-2
|Nature Biotechnology|2020|2.8k
Programmed DNA destruction by miniature CRISPR-Cas14 enzymes
|Science|2018|1.2k
Enhanced proofreading governs CRISPR–Cas9 targeting accuracy
|Nature|2017|1.2k
Actionable Diagnosis of Neuroleptospirosis by Next-Generation Sequencing
|New England Journal of Medicine|2014|1k